The feasibility and acceptability of a (mobile) application for men with lower urinary tract symptoms: a pilot study.

IF 4.2 2区 医学 Q1 UROLOGY & NEPHROLOGY
Stavros Gravas, Georgios Chasiotis, Mauro Gacci, Gokhan Calik, Andrea Liaci, Athanasios Dellis, Petros Sountoulides, M Pilar Laguna, Jean DE LA Rosette
{"title":"The feasibility and acceptability of a (mobile) application for men with lower urinary tract symptoms: a pilot study.","authors":"Stavros Gravas, Georgios Chasiotis, Mauro Gacci, Gokhan Calik, Andrea Liaci, Athanasios Dellis, Petros Sountoulides, M Pilar Laguna, Jean DE LA Rosette","doi":"10.23736/S2724-6051.25.06352-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The growing use of smartphones offers a key opportunity to monitor BPO/LUTS through well-designed medical apps. The primary objective of the study was to assess the feasibility and acceptability of a mobile app (MyBPHCare) for men with lower urinary tract symptoms (LUTS). Secondary objectives included medical adherence using electronic reminders and compliance of treatment with current guidelines.</p><p><strong>Methods: </strong>This was an observational cohort pilot study conducted in Greece, Türkiye, and Italy. Patients with LUTS, treatment-naïve or under treatment, older than 40 years were eligible. Patients received standard care according to physician's practice and duration of follow-up was 6 months. Standard questionnaires, diagnostic tools, medication, and follow-up visits were employed. Feasibility, acceptance, and satisfaction were assessed using a standardized, translated and validated app rating user questionnaire (uMARS). Patients' adherence to treatment and physicians' with guidelines were also recorded.</p><p><strong>Results: </strong>From a total of 157 patients, 68.15% filled in the uMARS questionnaire. All uMARS mean scores ranged between \"Acceptable\" and \"Good\": App Quality (3.43), Engagement (3.21), Functionality (3.47), Aesthetics (3.37), and Information (3.68). 96.3% of the participants would recommend using the app. Recorded adherence to medication was 47.85%, while a discrepancy between guidelines and real-life practice was found.</p><p><strong>Conclusions: </strong>MyBPHCare app is a possibly feasible application for virtually monitoring men with LUTS with good acceptance from the patients.</p>","PeriodicalId":53228,"journal":{"name":"Minerva Urology and Nephrology","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S2724-6051.25.06352-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The growing use of smartphones offers a key opportunity to monitor BPO/LUTS through well-designed medical apps. The primary objective of the study was to assess the feasibility and acceptability of a mobile app (MyBPHCare) for men with lower urinary tract symptoms (LUTS). Secondary objectives included medical adherence using electronic reminders and compliance of treatment with current guidelines.

Methods: This was an observational cohort pilot study conducted in Greece, Türkiye, and Italy. Patients with LUTS, treatment-naïve or under treatment, older than 40 years were eligible. Patients received standard care according to physician's practice and duration of follow-up was 6 months. Standard questionnaires, diagnostic tools, medication, and follow-up visits were employed. Feasibility, acceptance, and satisfaction were assessed using a standardized, translated and validated app rating user questionnaire (uMARS). Patients' adherence to treatment and physicians' with guidelines were also recorded.

Results: From a total of 157 patients, 68.15% filled in the uMARS questionnaire. All uMARS mean scores ranged between "Acceptable" and "Good": App Quality (3.43), Engagement (3.21), Functionality (3.47), Aesthetics (3.37), and Information (3.68). 96.3% of the participants would recommend using the app. Recorded adherence to medication was 47.85%, while a discrepancy between guidelines and real-life practice was found.

Conclusions: MyBPHCare app is a possibly feasible application for virtually monitoring men with LUTS with good acceptance from the patients.

(移动)应用于男性下尿路症状的可行性和可接受性:一项试点研究。
背景:智能手机的日益普及为通过精心设计的医疗应用程序监测BPO/LUTS提供了一个关键机会。该研究的主要目的是评估移动应用程序(MyBPHCare)对患有下尿路症状(LUTS)的男性的可行性和可接受性。次要目标包括使用电子提醒的医疗依从性和遵守现行指南的治疗。方法:这是一项在希腊、土耳其和意大利进行的观察性队列先导研究。年龄大于40岁的LUTS患者,treatment-naïve或正在接受治疗。患者接受医师规范治疗,随访6个月。采用标准问卷、诊断工具、药物和随访。可行性、接受度和满意度通过标准化、翻译和验证的应用程序评分用户问卷(uMARS)进行评估。患者对治疗的依从性和医生对指导方针的依从性也被记录下来。结果:157例患者中,68.15%的患者填写了uMARS问卷。所有uMARS的平均得分范围在“可接受”和“良好”之间:应用质量(3.43),用户粘性(3.21),功能(3.47),美学(3.37)和信息(3.68)。96.3%的参与者会推荐使用该应用程序。记录的药物依从性为47.85%,而指南与现实生活中的实践存在差异。结论:MyBPHCare应用程序可能是一种可行的应用程序,用于虚拟监测男性LUTS患者,患者接受度良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Minerva Urology and Nephrology
Minerva Urology and Nephrology UROLOGY & NEPHROLOGY-
CiteScore
8.50
自引率
32.70%
发文量
237
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信